235 related articles for article (PubMed ID: 27001960)
21. In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine.
Wu CJ; Lee SC; Huang HW; Tao MH
Vaccine; 2004 Mar; 22(11-12):1457-64. PubMed ID: 15063569
[TBL] [Abstract][Full Text] [Related]
22. Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology.
Eldi P; Cooper TH; Liu L; Prow NA; Diener KR; Howley PM; Suhrbier A; Hayball JD
Mol Ther; 2017 Oct; 25(10):2332-2344. PubMed ID: 28720468
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Kumar M; Sudeep AB; Arankalle VA
Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
[TBL] [Abstract][Full Text] [Related]
24. Next generation sequencing of DNA-launched Chikungunya vaccine virus.
Hidajat R; Nickols B; Forrester N; Tretyakova I; Weaver S; Pushko P
Virology; 2016 Mar; 490():83-90. PubMed ID: 26855330
[TBL] [Abstract][Full Text] [Related]
25. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
[TBL] [Abstract][Full Text] [Related]
26. Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.
Metz SW; Martina BE; van den Doel P; Geertsema C; Osterhaus AD; Vlak JM; Pijlman GP
Vaccine; 2013 Dec; 31(51):6092-6. PubMed ID: 24099875
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of an autophagy-targeted DNA vaccine against avian leukosis virus subgroup J.
Dai Z; Huang J; Lei X; Yan Y; Lu P; Zhang H; Lin W; Chen W; Ma J; Xie Q
Vaccine; 2017 Feb; 35(5):808-813. PubMed ID: 28049588
[TBL] [Abstract][Full Text] [Related]
28. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
29. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
[TBL] [Abstract][Full Text] [Related]
30. Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.
Shen X; Söderholm J; Lin F; Kobinger G; Bello A; Gregg DA; Broderick KE; Sardesai NY
Vaccine; 2012 Nov; 30(48):6946-54. PubMed ID: 22406460
[TBL] [Abstract][Full Text] [Related]
31. Protection of chickens from infectious bronchitis by in ovo and intramuscular vaccination with a DNA vaccine expressing the S1 glycoprotein.
Kapczynski DR; Hilt DA; Shapiro D; Sellers HS; Jackwood MW
Avian Dis; 2003; 47(2):272-85. PubMed ID: 12887187
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
[TBL] [Abstract][Full Text] [Related]
33. Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.
Kudrna JJ; Ugen KE
Hum Vaccin Immunother; 2015; 11(8):1921-6. PubMed ID: 26125436
[TBL] [Abstract][Full Text] [Related]
34. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
[TBL] [Abstract][Full Text] [Related]
35. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of recombinant glycoprotein D based prime boost approach against duck enteritis virus in mice model.
Aravind S; Kamble NM; Gaikwad SS; Shukla SK; Saravanan R; Dey S; Mohan CM
Microb Pathog; 2015 Nov; 88():78-86. PubMed ID: 26188265
[TBL] [Abstract][Full Text] [Related]
37. [Immunogenicity of N-protein of Puumala hantavirus for noninbred mice in the intramuscular administration of its gene DNA].
Chubukova OV; Khasanova SS; Nikonorov IuM; Kulagin VF; Chemeris AV; Vakhitov VA
Vopr Virusol; 2008; 53(4):38-41. PubMed ID: 18756816
[TBL] [Abstract][Full Text] [Related]
38. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever.
Sun Y; Li HY; Tian DY; Han QY; Zhang X; Li N; Qiu HJ
Vaccine; 2011 Oct; 29(46):8364-72. PubMed ID: 21888938
[TBL] [Abstract][Full Text] [Related]
39. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
[TBL] [Abstract][Full Text] [Related]
40. Protection of pigs against Aujeszky's disease by DNA vaccination.
Gerdts V; Jöns A; Makoschey B; Visser N; Mettenleiter TC
J Gen Virol; 1997 Sep; 78 ( Pt 9)():2139-46. PubMed ID: 9291999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
